Research Article: Characterization of ST and ST Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae from Patients with Ventilator-Associated Pneumonia
Abstract:
Klebsiella pneumoniae is a gram-negative opportunistic pathogen that can cause both community and hospital-acquired pneumonia, urinary tract infections, and bacteremia primarily in immunocompromised patients. Most experts agree that carbapenems are an effective treatment for serious infections brought on by Enterobacteriaceae that produce extended-spectrum beta-lactamases (ESBLs).– Because of the wide and irrational use of antibiotics, the number of carbapenemase-resistant Enterobacteriaceae (CRE) infections is increasing per year and antibiotic resistance has become an international problem., During –, the China Antimicrobial Surveillance Network (CHINET, http://www.chinets.com) reported that K. pneumoniae resistance rates to imipenem and meropenem have rapidly increased from % and .% to .% and .% respectively. There has been a significant increase in respiratory tract infections in intensive care units (ICUs) due to carbapenem-resistant K. pneumoniae (CRKP), which is considered a severe danger to public health as a pathogen associated with hospital-acquired infections (HAIs).– It is reported that –% of ICU patients suffer from ventilator-associated pneumonia (VAP). Meanwhile, treatment of CRKP-induced VAP in ICU patients is difficult because of the lack of multiple therapeutic drugs.
Introduction:
Klebsiella pneumoniae is a gram-negative opportunistic pathogen that can cause both community and hospital-acquired pneumonia, urinary tract infections, and bacteremia primarily in immunocompromised patients. Most experts agree that carbapenems are an effective treatment for serious infections brought on by Enterobacteriaceae that produce extended-spectrum beta-lactamases (ESBLs). – Because of the wide and irrational use of antibiotics, the number of carbapenemase-resistant Enterobacteriaceae (CRE) infections is…
Read more